Chris Mitchell - Concepedia

Author

Chris Mitchell

Also Known As

C D Mitchell, C Mitchell, C. D. Mitchell, C. Mitchell, C.D. Mitchell, Chris D Mitchell, Chris D. Mitchell, Chris Mitchell, Mitchell, Chris, Mitchell, Chris D

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

John Radcliffe Hospital University College London Sheffield Children's Hospital Great Ormond Street Hospital University of Oxford

About

Chris Mitchell is an author at John Radcliffe Hospital specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.2K
2	Public Health	3	3	412
3	Engineering	2	2	49
4	Health Sciences	1	1	17
5	Blood Transplantation	1	1	47

Chris Mitchell

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial Ajay Vora, Nick Goulden, Rachel Wade, The Lancet Oncology	2013	480
Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial Anthony V. Moorman, Hannah Ensor, Sue Richards, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaPediatric HematologyMedicineHematology	2010	388
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial Ajay Vora, Nick Goulden, Chris Mitchell, The Lancet Oncology Hematological MalignancyPost-remission TherapyYoung PeopleOncologyPediatric Epidemiology	2014	301
Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003 Katharine Patrick, Rachel Wade, Nick Goulden, British Journal of Haematology	2014	229
Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial Ajay Vora, Chris Mitchell, Lynne Lennard, The Lancet Hematological MalignancyOncologyPediatric HematologyMedicineRandomised Trial	2006	186
The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3 Gordan Vujanić, Anna Kelsey, Chris Mitchell, Medical and Pediatric Oncology	2002	155
Older Age Is an Adverse Prognostic Factor in Stage I, Favorable Histology Wilms’ Tumor Treated With Vincristine Monochemotherapy: A Study by the United Kingdom Children’s Cancer Study Group, Wilm’s Tumor Working Group Kathy Pritchard‐Jones, Anna Kelsey, Gordan Vujanić, Journal of Clinical Oncology	2003	113
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from <scp>UKALL</scp> 2003 Rachael Hough, Clare Rowntree, Nick Goulden, British Journal of Haematology	2015	89
Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS Eve Roman, Jill Simpson, Pat Ansell, European Journal of Cancer InfertilityHematologyReproductive HealthGynecologyPathology	2005	84
Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial S Jenkinson, Kenneth Koo, Marc R. Mansour, Leukemia Mrc Ukall 2003Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute Leukemia	2012	82

Page 1